A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002)

Clinical trial NCT02055547 · COMPLETED

Trial details

NCT number: NCT02055547
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2013-05-10
Primary completion: 2013-09-17
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.